AstraZeneca PLC (AZN)

AstraZeneca Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	238,709	208,650	209,909	174,284	131,174	129,337
Market Cap Growth	-2.37%	-0.60%	20.44%	32.86%	1.42%	34.47%
Enterprise Value	265,239	231,310	232,736	198,667	143,562	141,346
PE Ratio	37.82	35.04	63.84	1556.11	41.04	96.88
PS Ratio	5.01	4.56	4.73	4.66	4.93	5.30
PB Ratio	6.37	5.33	5.67	4.44	8.40	9.85
P/FCF Ratio	29.02	22.89	23.33	35.68	26.80	63.81
P/OCF Ratio	24.61	20.17	21.40	29.23	27.33	43.56
EV/Sales Ratio	5.57	5.05	5.25	5.31	5.39	5.80
EV/EBITDA Ratio	18.62	16.63	24.97	26.27	17.04	20.63
EV/EBIT Ratio	29.13	27.15	60.58	192.51	27.22	45.77
EV/FCF Ratio	32.24	25.37	25.86	40.67	29.33	69.73
Debt / Equity Ratio	0.92	0.73	0.79	0.78	1.30	1.39
Debt / EBITDA Ratio	2.43	2.06	3.14	4.07	2.42	2.66
Debt / FCF Ratio	4.20	3.14	3.25	6.30	4.16	8.99
Quick Ratio	0.69	0.62	0.68	0.75	0.77	0.70
Current Ratio	0.89	0.82	0.86	1.16	0.96	0.86
Asset Turnover	0.48	0.47	0.46	0.43	0.43	0.40
Interest Coverage	5.44	5.24	2.85	0.79	4.04	2.16
Return on Equity (ROE)	16.80%	15.90%	9.10%	0.40%	25.10%	10.80%
Return on Assets (ROA)	6.40%	6.10%	3.40%	0.10%	5.20%	2.20%
Return on Capital (ROIC)	10.37%	10.45%	7.47%	1.51%	11.55%	7.52%
Earnings Yield	2.65%	2.85%	1.57%	0.06%	2.44%	1.03%
FCF Yield	3.45%	4.37%	4.29%	2.80%	3.73%	1.57%
Dividend Yield	1.88%	2.20%	2.10%	2.40%	2.80%	2.80%
Payout Ratio	71.60%	75.50%	136.80%	3500.00%	114.80%	271.80%
Buyback Yield / Dilution	-0.13%	-9.32%	-8.68%	-0.92%	-2.68%
Total Shareholder Return	1.88%	2.07%	-7.22%	-6.28%	1.88%	0.12%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).